Mouse β-defensin 14 (Defb14) promotes tumor growth by inducing angiogenesis in a CCR6-dependent manner

Journal of Immunology

Volumn 188, Issue 10, 2012, Pages 4931-4939

  Röhrl, Johann ^a   Huber, Barbara ^a   Koehl, Gudrun E ^b   Geissler, Edward K ^b   Hehlgans, Thomas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 14; CHEMOKINE RECEPTOR CCR6; CXCL2 CHEMOKINE; IMMUNOGLOBULIN; LYMPHOTOXIN BETA RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CANCER TISSUE; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA TRANSFECTION; EX VIVO STUDY; FEMALE; FIBROSARCOMA; FLOW CYTOMETRY; HOST CELL; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; TUMOR CELL; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANIMALS; ANTIGENS, CD45; BETA-DEFENSINS; FEMALE; FIBROSARCOMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CCR6; TUMOR CELLS, CULTURED;

EID: 84861117223     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102442     Document Type: Article

References (32)

1. Lehrer, R. I., and T. Ganz. 2002. Defensins of vertebrate animals. Curr. Opin. Immunol. 14: 96-102. (Pubitemid 34085112)
2. Yang, D., O. Chertov, S. N. Bykovskaia, Q. Chen, M. J. Buffo, J. Shogan, M. Anderson, J. M. Schröder, J. M. Wang, O. M. Howard, and J. J. Oppenheim. 1999. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-528.
3. Röhrl, J., D. Yang, J. J. Oppenheim, and T. Hehlgans. 2010. Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells. J. Biol. Chem. 285: 7028-7034.
4. Soruri, A., J. Grigat, U. Forssmann, J. Riggert, and J. Zwirner. 2007. beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur. J. Immunol. 37: 2474-2486. (Pubitemid 47423617)
5. Kawsar, H. I., A. Weinberg, S. A. Hirsch, A. Venizelos, S. Howell, B. Jiang, and G. Jin. 2009. Overexpression of human beta-defensin-3 in oral dysplasia: potential role in macrophage trafficking. Oral Oncol. 45: 696-702.
6. Jin, G., H. I. Kawsar, S. A. Hirsch, C. Zeng, X. Jia, Z. Feng, S. K. Ghosh, Q. Y. Zheng, A. Zhou, T. M. McIntyre, and A. Weinberg. 2010. An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS One 5: e10993.
7. Röhrl, J., D. Yang, J. J. Oppenheim, and T. Hehlgans. 2010. Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J. Immunol. 184: 6688-6694.
8. Röhrl, J., D. Yang, J. J. Oppenheim, and T. Hehlgans. 2008. Identification and biological characterization of mouse beta-defensin 14, the orthologue of human beta-defensin 3. J. Biol. Chem. 283: 5414-5419.
9. García, J. R., F. Jaumann, S. Schulz, A. Krause, J. Rodríguez-Jiménez, U. Forssmann, K. Adermann, E. Klüver, C. Vogelmeier, D. Becker, et al. 2001. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity: its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 306: 257-264. (Pubitemid 32972384)
10. Taylor, K., D. J. Clarke, B. McCullough, W. Chin, E. Seo, D. Yang, J. Oppenheim, D. Uhrin, J. R. Govan, D. J. Campopiano, et al. 2008. Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3. J. Biol. Chem. 283: 6631-6639.
11. Shestakova, T., E. Zhuravel, L. Bolgova, O. Alekseenko, M. Soldatkina, and P. Pogrebnoy. 2008. Expression of human beta-defensins-1, 2 and 4 mRNA in human lung tumor tissue: a pilot study. Exp. Oncol. 30: 153-156. (Pubitemid 351951394)
12. Kesting, M. R., D. J. Loeffelbein, R. J. Hasler, K. D.Wolff, A. Rittig, M. Schulte, T. Hirsch, S. Wagenpfeil, F. Jacobsen, and L. Steinstraesser. 2009. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Invest. 27: 575-581.
13. Gambichler, T., M. Skrygan, J. Huyn, F. G. Bechara, M. Sand, P. Altmeyer, and A. Kreuter. 2006. Pattern of mRNA expression of beta-defensins in basal cell carcinoma. BMC Cancer 6: 163.
14. Kawsar, H. I., S. K. Ghosh, S. A. Hirsch, H. B. Koon, A. Weinberg, and G. Jin. 2010. Expression of human beta-defensin-2 in intratumoral vascular endothelium and in endothelial cells induced by transforming growth factor beta. Peptides 31: 195-201.
15. Kerbel, R. S. 2000. Tumor angiogenesis: past, present and the near future. Carcinogenesis 21: 505-515. (Pubitemid 30137936)
16. Hehlgans, T., B. Stoelcker, P. Stopfer, P. Müller, G. Cernaianu, M. Guba, M. Steinbauer, S. A. Nedospasov, K. Pfeffer, and D. N. Männel. 2002. Lymphotoxin-beta receptor immune interaction promotes tumor growth by inducing angiogenesis. Cancer Res. 62: 4034-4040. (Pubitemid 34791071)
17. Daller, B., W. Musch, J. Rohrl, A. V. Tumanov, S. A. Nedospasov, D. N. Mannel, W. Schneider-Brachert, and T. Hehlgans. 2010. Lymphotoxin-beta receptor activation by lymphotoxin-alpha(1)beta(2) and LIGHT promotes tumor growth in an NFkappaB-dependent manner. Int. J. Cancer.
18. Stoelcker, B., B. Ruhland, T. Hehlgans, H. Bluethmann, T. Luther, and D. N. Männel. 2000. Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature. Am. J. Pathol. 156: 1171-1176. (Pubitemid 30659994)
19. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408. (Pubitemid 34164012)
20. Koehl, G. E., F. Wagner, O. Stoeltzing, S. A. Lang, M. Steinbauer, H. J. Schlitt, and E. K. Geissler. 2007. Mycophenolate mofetil inhibits tumor growth and angiogenesis in vitro but has variable antitumor effects in vivo, possibly related to bioavailability. Transplantation 83: 607-614. (Pubitemid 46440251)
21. Coffelt, S. B., and A. B. Scandurro. 2008. Tumors sound the alarmin(s). Cancer Res. 68: 6482-6485.
22. Hinrichsen, K., R. Podschun, S. Schubert, J. M. Schröder, J. Harder, and E. Proksch. 2008. Mouse beta-defensin-14, an antimicrobial ortholog of human beta-defensin-3. Antimicrob. Agents Chemother. 52: 1876-1879. (Pubitemid 351614694)
23. Oppenheim, J. J., A. Biragyn, L. W. Kwak, and D. Yang. 2003. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann. Rheum. Dis. 62(Suppl. 2): ii17-ii21.
24. Winter, J., A. Pantelis, R. Reich, M. Martini, D. Kraus, S. Jepsen, J. P. Allam, N. Novak, and M. Wenghoefer. 2011. Human beta-defensin-1, -2, and -3 exhibit opposite effects on oral squamous cell carcinoma cell proliferation. Cancer Invest. 29: 196-201.
25. Kollmar, O., C. Scheuer, M. D. Menger, and M. K. Schilling. 2006. Macrophage inflammatory protein-2 promotes angiogenesis, cell migration, and tumor growth in hepatic metastasis. Ann. Surg. Oncol. 13: 263-275. (Pubitemid 43157422)
26. Brew, R., J. S. Erikson, D. C. West, A. R. Kinsella, J. Slavin, and S. E. Christmas. 2000. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12: 78-85. (Pubitemid 30042685)
27. Xie, K. 2001. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 12: 375-391. (Pubitemid 32851749)
28. Miller, L. J., S. H. Kurtzman, Y. Wang, K. H. Anderson, R. R. Lindquist, and D. L. Kreutzer. 1998. Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res. 18: 77-81. (Pubitemid 28174688)
29. Baroni, A., G. Donnarumma, I. Paoletti, I. Longanesi-Cattani, K. Bifulco, M. A. Tufano, and M. V. Carriero. 2009. Antimicrobial human beta-defensin-2 stimulates migration, proliferation and tube formation of human umbilical vein endothelial cells. Peptides 30: 267-272.
30. Conejo-Garcia, J. R., F. Benencia, M. C. Courreges, E. Kang, A. Mohamed-Hadley, R. J. Buckanovich, D. O. Holtz, A. Jenkins, H. Na, L. Zhang, et al. 2004. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 10: 950-958. (Pubitemid 39273736)
31. Wu, Z., D. M. Hoover, D. Yang, C. Boulègue, F. Santamaria, J. J. Oppenheim, J. Lubkowski, and W. Lu. 2003. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc. Natl. Acad. Sci. USA 100: 8880-8885. (Pubitemid 36899192)
32. Tyrrell, C., M. De Cecco, N. L. Reynolds, F. Kilanowski, D. Campopiano, P. Barran, D. Macmillan, and J. R. Dorin. 2010. Isoleucine/leucine2 is essential for chemoattractant activity of beta-defensin Defb14 through chemokine receptor 6. Mol. Immunol. 47: 1378-1382.